Partner at IMT, dedicated to innovation in medical imaging processing, with 2 FDA and CE labeled products. M’Ath® allows biometric measures on ultrasound images of superficial arteries, and particularly Carotid Intima-Media Thickness « CIMT », and Carotid Plaque Burden « CPB », 2 proven independent markers of subclinical atherosclerosis, and reliable long-term predictors of the risks of stroke and myocardial infarction. Neurinfarct®, applied to brain MRI diffusion images, predicts the potential growth of the infarction at the acute phase of stroke.
http://iimt.fr/
We’ve updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.